QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=C683E4B8FD3EEE9BDFAE7947FD7CDA8A;jsessionid=EC57C5E89017F1FEE4492775DABCAD43;jsessionid=BB490E952D5709A92F3415889C2468E4;jsessionid=67AFB838FF3AC58E9883A011ED1E6522;jsessionid=AB8502D2E6B59791729B8E475C71938D;jsessionid=36E0EA3DF19C9F6FE3FD57A9215F460C;jsessionid=E004B48E6E81C2AD11B3039CFEFDFDF7 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
3. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
4. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
5. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=1D75C74D5C77A9BAC3E0BBC789397CA4;jsessionid=C855386F3FC95269E723E7516712C4E6;jsessionid=C683E4B8FD3EEE9BDFAE7947FD7CDA8A;jsessionid=EC57C5E89017F1FEE4492775DABCAD43;jsessionid=BB490E952D5709A92F3415889C2468E4;jsessionid=67AFB838FF3AC58E9883A011ED1E6522;jsessionid=AB8502D2E6B59791729B8E475C71938D;jsessionid=36E0EA3DF19C9F6FE3FD57A9215F460C;jsessionid=E004B48E6E81C2AD11B3039CFEFDFDF7